GO
Loading...

Medtronic PLC

More

  • Feb 20- The U.S. Food and Drug Administration approved Medtronic Inc's device to permanently treat varicose veins on the legs. The VenaSeal closure system works by sealing the affected veins using an adhesive agent injected through a catheter. The device is manufactured by Covidien LLC, whose acquisition Medtronic completed last month.

  • Feb 20- The U.S. Food and Drug Administration said it approved Medtronic Inc's device to permanently treat varicose veins of the legs. The VenaSeal closure system works by sealing the affected superficial veins using an adhesive agent. The device is manufactured by Covidien LLC, whose acquisition Medtronic completed last month.

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- The S&P 500 ended above 2,100 at another record high on Tuesday as optimism grew that a debt deal would be reached with Greece and as bond prices sold off. In a possible sign of progress for Greece, a source told Reuters the country intends to ask for an extension of a loan agreement Wednesday.

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks inched higher on Tuesday, pushing the S&P 500 above 2,100 to another record intraday high as optimism grew that a debt deal would be reached with Greece. A source told Reuters that Greece intends to ask for an extension of a loan agreement tomorrow.

  • US STOCKS-Wall St flat, paring losses on Greece hopes Tuesday, 17 Feb 2015 | 12:49 PM ET

    *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks were flat on Tuesday, paring modest early losses and putting the S&P 500 back near record levels as optimism grew that a debt deal would be reached with Greece. A source told Reuters that Greece intends to ask for an extension of a loan agreement tomorrow.

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks edged lower on Tuesday, with the S&P 500 pulling back from record levels as investors continued to grapple with the uncertainty over a Greek debt deal and a fragile Ukraine truce. Much of the advance came on signs of progress for the debt deal in Greece, as well as reduced tension between...

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks edged lower on Tuesday, with the S&P 500 pulling back from record levels as investors continued to grapple with the uncertainty over a Greek debt deal and a fragile Ukraine truce. Much of the advance came on signs of progress for the debt deal in Greece, as well as reduced tension between...

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stock index futures pointed to a quiet open on Tuesday, the first trading session after the S&P 500 closed at a record high, although investors continued to watch the uncertainty over a Greek debt deal and a fragile Ukraine truce. Much of the advance came on signs of progress for the debt deal in...

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...

  • Medtronic tops Street 3Q forecasts Tuesday, 17 Feb 2015 | 7:39 AM ET

    MINNEAPOLIS— Medtronic Inc. on Tuesday reported fiscal third-quarter net income of $977 million. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 97 cents per share. Analysts expected $4.26 billion, according to Zacks.

  • Medtronic profit rises on higher cardiac device sales Tuesday, 17 Feb 2015 | 7:36 AM ET

    Feb 17- Medical device maker Medtronic Plc reported a 28 percent rise quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. The company, which completed its acquisition of Ireland- based Covidien Plc in January, said its net profit rose to $977 million, or 98 cents per share, for the third quarter ended Jan. 23, from $762...

  • Wall Street shaky as Greek debt talks collapse Tuesday, 17 Feb 2015 | 6:01 AM ET

    US stock index futures signaled a lower open on Tuesday, following Europe, after talks between Greece and its euro zone partners broke down.

  • After stroke, clot removal saves brain function - studies Wednesday, 11 Feb 2015 | 12:00 PM ET

    The two studies used devices made by Covidien, which was acquired by Medtronic PLC last month and helped pay for one of the trials. Stryker Corp and privately-held Penumbra Inc also manufacture devices approved for clot removal. Patrick Lyden, director of the Stroke Program at Cedars-Sinai Medical Center in Los Angeles, who was not involved in the studies.

  • M&A experts forecast there will be more major pharma deals in 2015 — but the U.K. won’t be a focus and the deals won’t be done for tax reasons.

  • Why one VC is investing, despite seeing a bubble Tuesday, 3 Feb 2015 | 11:07 AM ET

    Joe Horowitz has been in venture capital for three decades, so he knows how to spot a bubble. Too many billion-dollar start-ups is a big sign.

  • Medtronic closes on Covidien deal: CEO  Tuesday, 27 Jan 2015 | 9:47 AM ET

    Omar Ishrak, Medtronic chairman and CEO, discusses the strategic plan behind its merger with Covidien and the headwinds caused by the strong U.S. dollar.

  • Goldman Sachs: Watch out for energy M&A in 2015 Monday, 12 Jan 2015 | 7:14 AM ET
    A derrick hand removes the the plastic caps off the threaded ends of pipe used in the drilling process in Knox County, Ohio.

    Healthcare M&A looks set to be strong again this year, following deals from Shire and Roche. But Goldman Sachs says energy's a sector to watch too.

  • Tax inversion anyone? A year in M&A Monday, 29 Dec 2014 | 1:20 AM ET

    Mergers and acquisitions broke a seven-year losing streak in 2014, with $3.48 trillion worth of deals. CNBC looks at some of the year's highlights.

  • Dec 4- The top U.S. patent appeals court has thrown out a $176 million award for healthcare company Covidien Plc in a dispute with a Johnson& Johnson subsidiary over surgical instruments. Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., ruled on Thursday that Covidien's patent claims, which involve surgical cutting tools...

  • Treasuries fell on Tuesday, with prices pressured by a Wall Street rally and institutional investors readying for a $6 billion corporate bond deal from leading retailer Amazon. "Today was primarily about the rebound in equity prices," said Ian Lyngen, senior government bond strategist at CRT Capital in Stamford, Connecticut. "There is a lot of corporate issuance...